Risk of long COVID is higher in women and a link between SARS-CoV-2 infection and development of ME/CFS is shown, according ...
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...
Long COVID remains mysterious, with health care providers unsure which symptoms can be directly attributed to a COVID-19 ...
New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...
Three days before Trump’s swearing in to office, the US Department of Health and Human Services announced that EcoHealth ...
In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...
Vaccination prior to COVID-19 infection does not significantly affect neurologic symptoms in patients with long COVID.
Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...
A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...
Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...